+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Inhalation Anesthetics Market - Growth, Trends and Forecast 2017 - 2022

  • ID: 4388595
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 3
The global Inhalation Anesthetics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during the forecast period till 2021.

The market for inhalation anesthetic agents is increasing continuously due to the boost in its use because of a few factors. The increase in geriatric population causes a major fraction of population to be more susceptible to chronic diseases like cardiovascular, respiratory, cancer, neurological and other health ailments such as gastro, orthopedic and spinal problems. Other factors affecting the growth positively include elevating number of emergency services and increasing demand for lesser hospitalization days hence causing the healthcare providers to use such agents more frequently. One more reason of boost in inhalation anesthetic agents’ use is the improved accessibility to healthcare services for people across the world. This has led to more number of surgeries that are being conducted per year and hence more amounts of IAs being used.

The major anesthetic agents that are currently being used have generic competitors and hence market shares offset to some extent. Also, expiration of a few patents during recent years has caused the figures to suppress. The current market faces some key challenges for entry, say regulatory guidelines, and thus discourages new players.

The Inhalation Anesthetics market has been classified on the basis of the therapy type and geography. The classification on the basis of anesthesia used has two major classes. The first class includes Nitrous oxide as an inhalation anesthetic while the second one includes Halogenated agents like Halothane (Fluothane ®), Enflurane (Ethrane ®), Isoflurane (Forane ®), Desflurane (Suprane ®) and Sevoflurane (Ultane ®). Methoxyflurane (Penthrane ®), also an inhalation anesthetic has been stopped using frequently and is used primarily in veterinary procedures.

This report have been geographically segmented into North America, Europe, Asia-Pacific, Middle East & Africa and South America. The North American region have been further segmented into USA, Canada and Mexico. The Europe region have been sub-divided into Germany, France, UK, Spain, Italy, Scandinavia, Benelux and Rest of Europe. The Asia-Pacific market have been segmented into Japan, China, India, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of Middle East and Africa. The South American market have been segmented into Brazil, Argentina and rest of South America. North America accounts for the largest market share.

The current market lacks curative therapy and hence bringing innovative products and tapping the emerging economy will be a great opportunity for the market. The key players in the market are Baxter, Abbvie, Piramal Healthcare and Lunan Pharmaceuticals.

Key Deliverables:

Market analysis for the Inhalation Anesthetics market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the Global Inhalation Anesthetics market

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Note: Product cover images may vary from those shown
2 of 3
1.1 Study deliveratives
1.2 Market Definition
1.3 Review and forecast period years
1.4 General Study Assumptions
1.5 Report Description
2.1 Introduction
2.2 Analysis Methodology
2.3 Study timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
5.1 Current market scenario
5.2 Porters Five Force Analysis
5.2.1 Bargaining Power of suppliers
5.2.2 Bargaining power of buyers
5.2.3 Degree of competition
5.2.4 Threat of substitution
5.2.5 Threat of new entrants
6.1 Market Drivers
6.1.1 Increasing geriatric population prone to chronic diseases
6.1.2 Increasing number of emergency cases
6.1.3 Growing demand for lesser hospitalization days
6.1.4 Increasing accessibility to health services, thus surgeries
6.2 Market Restraints
6.2.1 Generic competition for almost all of the Halogenated agents
6.2.2 Recent Patent Expiries
6.3 Market opportunities
6.4 Key Challenges
6.4.1 High barriers to entry
7.1.1 Nitrous Oxide
7.1.2 Halogenated Agents Halothane (Fluothane ®) Enflurane (Ethrane ®) Isoflurane (Forane ®) Desflurane (Suprane ®) Sevoflurane (Ultane ®) Others
8. Global Inhalation Anaesthetics market by Geography - Regional shares and forecast
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Italy
8.2.5 Spain & Portugal
8.2.6 Scandinavia
8.2.7 Benelux
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 Baxter
10.2 Abbvie
10.3 Piramal Healthcare
10.4 Lunan Pharmaceuticals
10.5 Others
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3